Magnus Life Science

IN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca

IN VITRO DIAGNOSTICS InSilixa Inc. InSilixa raises $13mm in early-stage round Molecular diagnostics start-up InSilixa Inc. raised $13mm in an early-stage financing led by PointGuard Ventures a

A new life sciences company, Magnus Life Science , has been set up in Britain with £15.5 million ($25 million) in seed funding and a business model that is unique to the U.K.; the model has similar